Related Experiment Video
Updated: Jun 27, 2025

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
Published on: July 19, 2019
Management of multiple sclerosis in older adults: review of current evidence and future perspectives
Kimberly A DiMauro1, Carol Swetlik1, Jeffrey A Cohen2
1Mellen Center for MS Treatment and Research, Cleveland Clinic, Neurological Institute, Cleveland, OH, USA.
Importance:
The prevalence of multiple sclerosis (MS) and aging MS patients is increasing worldwide. There is a need to better understand this MS sub-population, which historically is underrepresented in the literature. This narrative review examines the evolving demographics, disease course, and treatments for older adults with MS (OAMS) to address current knowledge gaps and highlight areas critical for future research.
Observations:
OAMS populations require special consideration by clinicians. Older individuals have different care needs than individuals with adult onset MS who are mid-life or younger. Comorbidities, an aging immune system, increasing neurodegeneration, decreasing neurologic reserve, changing benefit/risk relationship for disease modifying therapies (DMTs), and wellness require special attention to provide holistic comprehensive care. Active areas of research include potential cessation of DMTs and novel disease targets.
Conclusions And Relevance:
This review highlights both the current knowledge and information gaps in the literature that are critical to understanding and properly managing OAMS. The aims are to inform MS clinicians in their current practice, as well as inspire future studies which are critical to providing quality and evidence-based care for OAMS.
Insights
Older adults with multiple sclerosis (MS) require specialized care due to unique health needs. This review addresses knowledge gaps in managing aging MS patients, focusing on demographics, disease progression, and treatment strategies.
Area of Science:
- Neurology
- Geriatrics
- Immunology
Background:
- The global prevalence of multiple sclerosis (MS) and its aging patient population is rising.
- Older adults with MS (OAMS) are an underrepresented demographic in current medical literature.
- Understanding the unique needs of OAMS is crucial for effective management.
Purpose of the Study:
- To examine the evolving demographics, disease course, and treatment considerations for OAMS.
- To identify and address critical knowledge gaps in the management of OAMS.
- To inform clinical practice and guide future research for OAMS.
Main Methods:
- This narrative review synthesizes existing literature on OAMS.
- It analyzes demographic trends, disease progression patterns, and therapeutic interventions.
- Key areas of focus include comorbidities, immune system changes, and neurodegeneration in OAMS.
Main Results:
- OAMS present distinct clinical challenges compared to younger MS patients.
- Factors such as comorbidities, aging immune system, and reduced neurological reserve necessitate tailored care.
- The benefit-risk profile of disease-modifying therapies (DMTs) requires careful evaluation in older individuals.
Conclusions:
- Significant knowledge gaps persist in understanding and managing OAMS.
- Holistic care approaches are essential, considering wellness and potential DMT cessation.
- Further research is critical to ensure evidence-based, high-quality care for the growing OAMS population.
More Related Videos
08:48Adapted Resistance Training Improves Strength in Eight Weeks in Individuals with Multiple Sclerosis
Published on: January 29, 2016
09:38Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination
Published on: September 12, 2016
Related Concept Videos
Cognitive Development During Adulthood
Parkinson's Disease: Overview
Alzheimer's Disease: Treatment
Aging
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...